BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9063755)

  • 1. Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
    Krcmery V; Trup J; Kunova A; Spanik S; Drgona L; Oravcova E; Studena M; Lacka J; Sevcikova L; Koren P; Kukuckova E; Stopkova K; Krupova I; Grausova S; Svec J
    Int J Clin Pharmacol Res; 1996; 16(2-3):43-9. PubMed ID: 9063755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
    Krcméry V; Trupl J; Kunová A; Spánik S; Ilavská I; Hel'pianska L; Bezáková I; Drgona L; Oravcová E; Studená M; Lacka J; Sevcíková L; Koren P; Kukucková E; Stopková K; Krupová I; Grausová S; Svec J
    Bratisl Lek Listy; 1996 Nov; 97(11):647-51. PubMed ID: 9117427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients.
    Harris AD; Smith D; Johnson JA; Bradham DD; Roghmann MC
    Clin Infect Dis; 2002 Feb; 34(3):340-5. PubMed ID: 11774081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit.
    Ozkurt Z; Ertek M; Erol S; Altoparlak U; Akcay MN
    Burns; 2005 Nov; 31(7):870-3. PubMed ID: 15975720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
    Zavascki AP; Cruz RP; Goldani LZ
    J Hosp Infect; 2005 Feb; 59(2):96-101. PubMed ID: 15620442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
    Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
    J Infect; 2006 Jul; 53(1):30-5. PubMed ID: 16253333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case-control study on the risk factors of nosocomial infection caused by imipenem-resistant Pseudomonas aeruginosa].
    Peng SH; Jin ZJ; Luo L; Li CR
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jul; 26(7):511-4. PubMed ID: 16335003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
    Suárez C; Peña C; Tubau F; Gavaldà L; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
    J Infect; 2009 Apr; 58(4):285-90. PubMed ID: 19297028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
    Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
    J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients.
    Spanik S; Trupl J; Kunova A; Drgona L; Salek T; Mardiak J; Kukuckova E; Studena M; Pichna P; Oravcova E; Grey E; Koren P; Svec J; Lacka J; Sufliarsky J; Krcmery V
    J Med Microbiol; 1997 Jun; 46(6):517-23. PubMed ID: 9350206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.
    Spánik S; Trupl J; Kunová A; Pichna P; Helpianska L; Ilavská I; Kukucková E; Lacka J; Grausová S; Stopková K; Drgona L; Krcméry V
    Neoplasma; 1996; 43(4):235-8. PubMed ID: 8931747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
    Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
    Cao B; Wang H; Sun H; Zhu Y; Chen M
    J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patients.
    Micol JB; de Botton S; Guieze R; Coiteux V; Darre S; Dessein R; Leroy O; Yakoub-Agha I; Quesnel B; Bauters F; Beaucaire G; Alfandari S
    Haematologica; 2006 Aug; 91(8):1134-8. PubMed ID: 16885056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.
    Mammina C; Di Carlo P; Cipolla D; Casuccio A; Tantillo M; Plano MR; Mazzola A; Corsello G
    Acta Pharmacol Sin; 2008 Dec; 29(12):1486-92. PubMed ID: 19026168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa bacteraemia in cancer patients.
    Krcmery V; Koprnova J; Gogova M; Grey E; Korcova J
    J Infect; 2006 Jun; 52(6):461-3. PubMed ID: 16621000
    [No Abstract]   [Full Text] [Related]  

  • 19. [Imipenem resistance in Pseudomonas aeruginosa].
    Fille M; Bauernfeind A; Eberlein E; Jungwirth R; Schneider I; Speer G; Dierich MP; Allerberger F
    Wien Klin Wochenschr; 1998 Oct; 110(20):715-20. PubMed ID: 9857429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW; Singh S; Johnson RH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.